PharmaCyte Biotech, Inc.
Hedge Funds Holdings
Last updated:
PharmaCyte Biotech, Inc.‘s stocks are currently a part of 17 hedge funds’ portfolios, which represents 12.21% of the total amount of its stocks outstanding. This makes up a total of 2.31M shares of PharmaCyte Biotech, Inc.. Compared to the previous quarter, the number fell by -31.62% or -1.07M shares fewer. As for the holding position changes, 23.53% (4) of current hedge fund investors increased the number of shares held, 23.53% (4) of current holders sold a part of the shares held, and 23.53% (4) closed the holdings completely. 5 hedge funds are new holders of PharmaCyte Biotech, Inc. stock in Q1 2023, it is 29.41% of total holders.
Hedge funds holding PharmaCyte Biotech (Q2 2018 – Q1 2023)
Q2 2018 | 4 |
---|---|
Q3 2018 | 4 |
Q4 2018 | 4 |
Q1 2019 | 4 |
Q2 2019 | 3 |
Q3 2019 | 1 |
Q4 2019 | 1 |
Q1 2020 | 1 |
Q2 2020 | 2 |
Q3 2020 | 1 |
Q4 2020 | 1 |
Q1 2021 | 2 |
Q2 2021 | 2 |
Q3 2021 | 14 |
Q4 2021 | 18 |
Q1 2022 | 17 |
Q2 2022 | 23 |
Q3 2022 | 21 |
Q4 2022 | 27 |
Q1 2023 | 17 |
Hedge funds changes in PharmaCyte Biotech positions (Q2 2018 – Q1 2023)
Q2 2018 | 0 | 1 | 2 | 0 | 1 |
---|---|---|---|---|---|
Q3 2018 | 0 | 0 | 2 | 0 | 2 |
Q4 2018 | 0 | 1 | 1 | 1 | 1 |
Q1 2019 | 0 | 0 | 1 | 0 | 3 |
Q2 2019 | 0 | 0 | 1 | 1 | 1 |
Q3 2019 | 0 | 0 | 0 | 2 | -1 |
Q4 2019 | 0 | 0 | 0 | 0 | 1 |
Q1 2020 | 0 | 0 | 0 | 0 | 1 |
Q2 2020 | 1 | 1 | 0 | 0 | 0 |
Q3 2020 | 0 | 0 | 1 | 1 | -1 |
Q4 2020 | 0 | 0 | 0 | 0 | 1 |
Q1 2021 | 1 | 0 | 0 | 0 | 1 |
Q2 2021 | 0 | 0 | 0 | 0 | 2 |
Q3 2021 | 14 | 0 | 0 | 2 | -2 |
Q4 2021 | 7 | 6 | 4 | 3 | -2 |
Q1 2022 | 4 | 7 | 3 | 5 | -2 |
Q2 2022 | 9 | 7 | 5 | 2 | 0 |
Q3 2022 | 3 | 9 | 5 | 6 | -2 |
Q4 2022 | 12 | 5 | 4 | 6 | 0 |
Q1 2023 | 5 | 4 | 4 | 4 | 0 |
Hedge funds changes in PharmaCyte Biotech stock options (Q2 2018 – Q1 2023)
Q2 2018 | 0 | 0 |
---|---|---|
Q3 2018 | 0 | 0 |
Q4 2018 | 0 | 0 |
Q1 2019 | 0 | 0 |
Q2 2019 | 0 | 0 |
Q3 2019 | 0 | 0 |
Q4 2019 | 0 | 0 |
Q1 2020 | 0 | 0 |
Q2 2020 | 0 | 0 |
Q3 2020 | 0 | 0 |
Q4 2020 | 0 | 0 |
Q1 2021 | 0 | 0 |
Q2 2021 | 0 | 0 |
Q3 2021 | 234,000 | 140,000 |
Q4 2021 | 226,000 | 305,000 |
Q1 2022 | 207,000 | 158,000 |
Q2 2022 | 100,000 | 2,012,000 |
Q3 2022 | 390,000 | 1,850,000 |
Q4 2022 | 521,742 | 566,181 |
Q1 2023 | 291,000 | 90,782,000 |